5 active not recruiting, 4 recruiting, 2 terminated, 1 completed. 5 Phase 2, 3 Not applicable, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Active not recruiting 3, Terminated 2 |
| Not applicable | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 1 | 3 | Active not recruiting 2, Recruiting 1 |
Follow Thyroid Gland Carcinoma: new trials by email Literature Review of Thyroid Gland Carcinoma trials Research Report on Thyroid Gland Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers Computed Tomography, Fludeoxyglucose F-18, Gallium Ga 68 FAPi-46 - Anal Carcinoma, Bladder Carcinoma | Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 30 | 2025-08-01 | 2026-10-20 |
| Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study Internet Mobile Technology, Internet-Based Intervention, Questionnaire Administration - Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage II Cutaneous Melanoma AJCC v8 | Not applicable | Completed | Fred Hutchinson Cancer Center | 549 | 2022-10-23 | 2026-01-23 |
| Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules Diagnostic Procedure, Electronic Health Record Review, Needle Biopsy - Thyroid Gland Carcinoma | Not applicable | Recruiting | City of Hope Medical Center | 1450 | 2021-12-23 | 2026-10-16 |
| Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers Computed Tomography, Gallium Ga 68 FAPi-46, Positron Emission Tomography - Bladder Carcinoma, Cervical Carcinoma | Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 26 | 2020-08-27 | 2026-02-05 |
| An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance Imaging - Thyroid Gland Carcinoma | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 42 | 2020-08-12 | 2026-05-22 |
| Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer Biospecimen Collection, Electronic Health Record Review - Thyroid Gland Carcinoma, Thyroid Gland Nodule | Recruiting | Jonsson Comprehensive Cancer Center | 250 | 2020-02-21 | 2026-03-10 | |
| Effect of Polyglycolic Acid Mesh (Neoveil) in Thyroid Cancer Surgery Neoveil (Polyglycolic Acid Mesh) - Thyroid Gland Carcinoma, Thyroid Cancer | Not applicable | Unknown | Seoul National University Hospital | 330 | 2018-05-01 | 2018-04-27 |
| Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer Gallium Ga 68-labeled PSMA-11, Magnetic Resonance Imaging, Positron Emission Tomography (PET) - Thyroid Gland Carcinoma | Phase 2 | Terminated | University of California, San Francisco | 12 | 2018-03-19 | 2021-06-29 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Biospecimen Collection, Computed Tomography, Echocardiography Test - Acinar Cell Carcinoma, Adenoid Cystic Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 798 | 2017-01-30 | 2026-06-17 |
| Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord Computed Tomography, Quality-of-Life Assessment, Questionnaire Administration - Malignant Digestive System Neoplasm, Metastatic Head and Neck Carcinoma | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 60 | 2016-08-29 | 2026-10-07 |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) Adavosertib, Afatinib, Afatinib Dimaleate - Advanced Lymphoma, Advanced Malignant Solid Neoplasm | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 6452 | 2015-08-17 | 2026-10-26 |
| Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy Doxepin Hydrochloride, Placebo, Quality-of-Life Assessment - Esophageal Carcinoma, Hypopharyngeal Carcinoma | Phase 2 | Terminated | Mayo Clinic | 5 | 2014-04-14 | 2019-10-01 |
| Identification and Differentiation of Thyroid Nodules by Acoustic Imaging and Viscoelastic Parameters Non-Interventional Study - Thyroid Gland Carcinoma | Recruiting | Mayo Clinic | 650 | 2009-05-17 | 2026-03-27 |
Thyroid Neoplasms (13) · Sarcoma (4) · Carcinoma, Hepatocellular (3) · Carcinoma, Transitional Cell (3) · Cholangiocarcinoma (3) · Colorectal Neoplasms (3) · Esophageal Neoplasms (3) · Hematologic Neoplasms (3) · Lymphoma (3) · Urinary Bladder Neoplasms (3) · Uterine Cervical Neoplasms (3) · Adrenal Gland Neoplasms (2) · Brain Neoplasms (2) · Breast Neoplasms (2) · Carcinoma, Renal Cell (2)
Endocrine Gland Neoplasms (13) · Endocrine System Diseases (13) · Head and Neck Neoplasms (13) · Neoplasms (13) · Neoplasms by Site (13) · Thyroid Diseases (13) · Digestive System Diseases (7) · Digestive System Neoplasms (7) · Neoplasms by Histologic Type (7) · Gastrointestinal Diseases (6) · Neoplasms, Glandular and Epithelial (6) · Adenocarcinoma (5) · Carcinoma (5) · Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5)
Magnetic Resonance Spectroscopy (6) · FAPI-46 (2) · Fluorodeoxyglucose F18 (2) · Nivolumab (2) · Specimen Handling (2) · X-Rays (2) · 2-(3-(2-(1-isopropyl-3-methyl-1H-1,2-4-triazol-5-yl)-5,6-dihydrobenzo(f)imidazo(1,2-d)(1,4)oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide (1) · 2C4 antibody (1) · AZD4547 (1) · Ado-Trastuzumab Emtansine (1) · Afatinib (1) · Biopsy (1) · Biopsy, Needle (1) · CT-P6 (1) · CTLA-4 Antigen (1)
Jonsson Comprehensive Cancer Center (3) · M.D. Anderson Cancer Center (2) · Mayo Clinic (2) · National Cancer Institute (NCI) (2) · City of Hope Medical Center (1) · Fred Hutchinson Cancer Center (1) · Seoul National University Hospital (1) · University of California, San Francisco (1)
United States (12) · Guam (2) · Puerto Rico (1) · South Korea (1)
Jeremie Calais (2) · Azra Alizad, MD (1) · James Wu (1) · Jing Li (1) · John H Yim (1) · K. Scott Baker (1) · Keith T Flaherty (1) · Robert Flavell, MD, PhD (1) · Sandip P Patel (1) · Stephen Y Lai (1) · Terence Sio (1)
PMID 25860987, PMID 26586415, PMID 26597705, PMID 27784046, PMID 31969335, PMID 32463741, PMID 33048619, PMID 33362722, PMID 33882143, PMID 34380663, PMID 34716198, PMID 35133871, PMID 35138919, PMID 36351402, PMID 37053535, PMID 37322121, PMID 37934000, PMID 38243705, PMID 38358334, PMID 38591867, PMID 39067873, PMID 39343510, PMID 39417692, PMID 39583952, PMID 39666929, PMID 39693587, PMID 39856213, PMID 39913886, PMID 40402690, PMID 40588371, PMID 40865033, PMID 41066729, PMID 41672597, PMID 41892875, PMID 41995270, PMID 42499790
P30CA015083 (1), P30CA016672 (1), P30CA033572 (1), R01CA148994 (1), U01CA246659 (1), U10CA180820 (1), U10CA180888 (1), U24CA196172 (1)